Final Program

SUNDAY • MAY 15 127
909 Spatiotemporal Overexpression of Human Resistin in Mouse Lungs
Results in Vascular Remodeling and Pulmonary Hypertension/X.
Fang, J. Gomez-Arroyo, J. Skinner, L. Meuchel, K. Yamaji-Kegan, J.
Dong, C. Fan, Z. Zhu, R. John, Baltimore, MD, p.A2795
910 Amelioration of SU5416/Hypoxia-Induced Pulmonary
Hypertension Following Treatment with EMAPII-Neutralizing
Antibodies/M. Clauss, M. Bednorz, L. Green, R. Yi, M. Seimetz, I.
Petrache, T. Lahm, Indianapolis, IN, p.A2796
911 Dasatinib Causes Pulmonary Endothelial Damage and
Increases Endothelial Permeability/E.-M. Jutant, C. Phan, L. Tu,
Y. Tamura, R. Thuillet, M. Le Hiress, E. Fadel, G. Simonneau, A.
Seferian, D. Montani, A. Huertas, M. Humbert, J. Aman, C.
Guignabert, Le Plessis-Robinson, France, p.A2797
912 The Extracellular Matrix Collagen Fragment AcPGP Facilitates
Pulmonary Vascular Remodeling Through Rho Kinase
Signaling/D.W. Russell, G.A. Payne, D. Xing, Y. Wu, L. Viera, T.
Szul, J. Gautney, C.M. McNicholas-Bevensee, A. Gaggar, Q. Yang,
X. Xu, P.L. Jackson, M.T. Dransfield, J.E. Blalock, J.M. Wells,
Birmingham, AL, p.A2798
913 Transgenic Endothelial Specific HIV-Nef Expression Induces
Vascular Dysfunction and Mild Pulmonary Hypertension/S.
Chelvanambi, M. Clauss, N. Dahl, X. Chen, A. Obukhov, K.L.
March, T. Lahm, P. Jolicoeur, Indianapolis, IN, p.A2799
914 Role of the Macrophage Mineralocorticoid Receptor in
Pulmonary Arterial Hypertension/D.P. Menon, K.C. Penumatsa,
R. Warburton, E.A. Yu, D. Toksoz, N.S. Hill, B.L. Fanburg, U.
Kayyali, I.R. Preston, Boston, MA, p.A2800
915 Influence of Sex on TGFb and BMPR2 Signalling in the
Hypertrophic Right Ventricle in a Mouse Model of Pulmonary
Arterial Hypertension/D. Morales-Cano, K.M. Mair, F. Perez
Vizcaino, M. MacLean, Madrid, Spain, p.A2801
916 Vascular Olfactory Receptors: New Suspects in Pulmonary
Arterial Hypertension/A. Courboulin, M. Quatredeniers, G. Sanz,
S. Breuils-Bonnet, M. Vocelle, M. Lafond, F. Antigny, F. Perros, S.
Bonnet, E. Pajot-Augy, M. Humbert, S. Cohen-Kaminsky, Le
Plessis Robinson, France, p.A2802
917 Stiffness-Dependent Alteration of BMP Signaling and Vascular
Smooth Muscle Cell Growth in Pulmonary Arterial
Hypertension/K. Ihida-Stansbury, R. Malik, M. Chokshi, L. Philip,
S. Nguyen, Philadelphia, PA, p.A7802
918 Therapeutic Proof-of-Concept for Novel siRNA Technology in
Experimental Pulmonary HYpertension/R.S. Baliga, A.J. Moyes,
I.C. Villar, U. Schaeper, L. Iannone, A.J. Hobbs, London, United
Kingdom, p.A7803
A108
POSTER DISCUSSION SESSION
MICRO RNAS, RNA SEQ, LNCRNA: BIOLOGY AND
FUNCTION
2:15 p.m. - 4:15 p.m. MOSCONE CENTER
Room 2024 (West Building, Level 2)
Poster Viewing 2:15-3:00
Discussion 3:00-4:15
601 Differential miRNome Expression Profiles of Alveolar Cells in
Humanized SP-A2 Transgenic and SP-A Knockout Male Mice,
and Cell-Specific Biogenesis of miRNAs Predicted to Regulate
SP-A2/G.T. Noutsios, T.M. Umstead, X. Zhang, J. Floros, Hershey,
PA, p.A2803
602 Epithelial Barrier Associated MicroRNAs Are Reduced in
Rhinovirus Infected Epithelial from Healthy and Asthmatic
Donors/N. Day, E. Wilkinson, M. Hardyman, G. Dingley, R.
Felwick, R. Martinez-Nunez, T. Sanchez-Elsner, J. Collins,
Southampton, United Kingdom, p.A2804
603 MicroRNA-34a Blockade Partially Restores Normal Septal
Thickness in an Experimental Animal Model of
Bronchopulmonary Dysplasia/J. Ruiz Camp, J. Quantius, P. Arndt,
I. Mizikova, S. Herold, W. Seeger, R.E. Morty, Bad Nauheim,
Germany, p.A2805
604 A Role for microRNA-29c in Arrested Alveolarization
Associated with Experimental Bronchopulmonary
Dysplasia/D.E. Surate Solaligue, D. Silva, W. Seeger, R.E. Morty,
Bad Nauheim, Germany, p.A2806
605 Identification of Novel microRNA Targets in Neonatal Lungs of
CTGF-Transgenic Mice/C. Miranda, R. Zambrano, S. Luo, C.
Dong, S. Wu, Miami, FL, p.A2807
606 MicroRNA-145 Regulates TGF-b1 Mediated Down-Regulation
of CFTR Expression in CF and Non-CF Airway Epithelia/
F.M. Lutful Kabir, W.T. Harris, Birmingham, AL, p.A2808
607 Peripheral Blood MicroRNA Signature Differentiates
Sarcoidosis/N.G. Casanova, T. Zhou, J. Navarrete, K.S. Knox,
J.G.N. Garcia, Tucson, AZ, p.A2809
608 Analysis of MicroRNAs in the Developing Mouse Lung Reveals
Changes Relevant to Adult Human Disease/F. Ahangari, J.
Herazo-Maya, B. Juan-Guardela, A. Munivar, A.E. Tzouvelekis, T.
Nicola, N. Ambalavanan, Z. Bar-Joseph, J. Hagood, N. Kaminski,
New Haven, CT, p.A2810
609 Identification of Serum Extracellular Vesicle microRNA as a
Biomarker for Prognosis in Idiopathic Pulmonary Fibrosis/T.
Makiguchi, M. Yamada, Y. Yoshioka, H. Sugiura, A. Koarai, H.
Kubo, T. Ochiya, M. Ichinose, Sendai, Japan, p.A2811
610 Serum MicroRNA in IPF Patients Display Fibrotic Profiles
-Potential Prognostic Indicators or Markers of Disease
Burden?/P. Minnis, R. Kane, G. Cooke, R. Lumsden, S.M. Walsh,
S. Whitty, A. Fabre, M.P. Keane, Dublin, Ireland, p.A2812
SUNDAY AFTERNOON
ATS 2016 • San Francisco